Biologic mechanisms and clinical consequences of pregnancy alloimmunization

American Journal of Transplantation

Volumn 18, Issue 5, 2018, Pages 1059-1067

  Porrett, Paige M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

alloantibody; basic (laboratory) research science; clinical research practice; histocompatibility; immune regulation; immunobiology; lymphocyte biology; pregnancy; sensitization

Indexed keywords

ALLOANTIGEN; BIOLOGICAL PRODUCT; HLA ANTIBODY; TISSUE ANTIGEN; ALLOANTIBODY; HLA ANTIGEN;

ALLOIMMUNIZATION; B LYMPHOCYTE; CELL FATE; CLINICAL PRACTICE; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; KNOWLEDGE; KNOWLEDGE BASE; MATERNAL PLASMA; NONHUMAN; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; BLOOD; FETUS; GRAFT REJECTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; ORGAN TRANSPLANTATION; PREGNANCY COMPLICATION; REGULATORY T LYMPHOCYTE;

FEMALE; FETUS; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNOLOGIC MEMORY; ISOANTIBODIES; ISOANTIGENS; ORGAN TRANSPLANTATION; PREGNANCY; PREGNANCY COMPLICATIONS; T-LYMPHOCYTES, REGULATORY;

EID: 85043325094     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.14673     Document Type: Review

References (48)

1. van Rood JJ, Eernisse JG, van Leeuwen A. Leucocyte antibodies in sera from pregnant women. Nature. 1958;181(4625):1735-1736.
2. Regan L, Braude PR, Hill DP. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod. 1991;6(2):294-298.
3. Hönger G, Fornaro I, Granado C, Tiercy JM, Hösli I, Schaub S. Frequency and determinants of pregnancy-induced child-specific sensitization. Am J Transplant. 2013;13(3):746-753.
4. Masson E, Vidal Ch, Deschamps M, et al. Incidence and risk factors of anti-HLA immunization after pregnancy. Hum Immunol. 2013;74:946-951.
5. Kussel L, Herkner H, Wahrmann M, et al. Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetes. Sci Rep. 2017;7(1):13524.
6. Lee J, Romero R, Xu Y, et al. Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection. Am J Rep Immunol. 2011;66:510-526.
7. van Kampen CA, Versteeg-van der Voort Maarschalk MF, Langerak-Langerak J, Roelen DL, Claas FHJ Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child. Human Immunol. 2002;63:452-458
8. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion related acute lung injury (TRALI) risk reduction strategy. Transfusion. 2009;49(9):1825-1835.
9. Vilches M, Nieto A. Analysis of pregnancy-induced anti-HLA antibodies using Luminex platform. Transpl Proc. 2015;47:2608-2610.
10. Aghaeepour N, Ganio EA, Mcilwain D, et al. An immune clock of human pregnancy. Sci Immunol. 2017;2(15):eaan2946.
11. Redfield RR, Scalea JR, Zens TJ, et al. The mode of sensitization and its influence on allograft outcomes in highly sensitized kidney transplant recipients. Nephrol Dial Transplant. 2016;31(10):1746-1753.
12. Bromberger B, Spragan D, Hashmi S, et al. Pregnancy-induced sensitization promotes sex disparity in living donor kidney transplantation. J Am Soc Nephrol. 2017;28(10):3025-3033.
13. Higgins R, Lowe D, Daga S, et al. Pregnancy-induced HLA antibodies respond more vigorously after renal transplantation than antibodies induced by prior transplantation. Hum Immunol. 2015;76:546-552.
14. Pollack MS, Trimarchi HM, Riley DJ, Casperson PR, Manyari LE, Suki WN. Shared cadaver donor-husband HLA class I mismatches as a risk factor for renal graft rejection in previously pregnant women. Hum Immunol. 1999;60:1150-1155.
15. Ghafari A. Offspring-to-mother and husband-to-wife renal transplantation: a single-center experience. Transpl Proc. 2008;40(1):140-142.
16. Mahanty HD, Cherikh WS, Chang GJ, Baxter-Lowe LA, Roberts JP. Influence of pretransplant pregnancy on survival of renal allografts from living donors. Transplantation. 2001;72:228-232.
17. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 1995;333(6):333-336.
18. Cohen EP, Rosendale JD, Bong CJH, Hariharan S. Benefit of child-to-parent kidney donation. Am J Transplant. 2003;3:865-872.
19. Choi JY, Kwon OJ, Kange CM. The effect of donor-recipient relationship on long-term outcomes of living related donor renal transplantation. Transpl Proc. 2012;44:257-260.
20. Cohen JB, Owei L, Sawinski DL, Porrett PM. Inferior long-term allograft and patients outcomes among recipients of offspring living donor kidneys [published online ahead of print December 21, 2017]. Am J Transplant. https://doi.org/10.1111/ajt.14631
21. Miles CD, Schaubel DE, Liu D, Port FK, Rao PS. The role of donor-recipient relationship in long-term outcomes of living donor renal transplantation. Transplantation. 2008;85(10):1483-1488.
22. Bianchi DW, Zickwolf GK, Weill GJ, Sylvesters S, DeMaria MA. Male progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Nat Acad Sciences. 1996;93(2):705-708.
23. Bianchi DW, Mahr A, Zickwolf GK, Houseal TW, Flint AF, Klinger KW. Detection of fetal cells with 47, XY,+21 karyotype in maternal peripheral blood. Hum Genet. 1992;90(4):368-370.
24. Rijnink EC, Penning ME, Wolterbeek R, et al. Tissue microchimerism is increased during pregnancy: a human autopsy study. Mol Hum Reprod. 2015;21(11):857-864.
25. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485-487.
26. Mitchell MD, Peiris HN, Kobayashi M, et al. Placental exosomes in normal and complicated pregnancy. Am J Obstet Gynecol. 2015;213(4 suppl):S173-S181.
27. Tay CS, Tagliani E, Collins MK, Erlebacher A. Cis-acting pathways selectively enforce the non-immunogenicity of shed placental antigen for maternal CD8 T cells. PLoS ONE. 2013;8(12):e84064.
28. Erlebacher A, Vencato D, Price KA, Zhang D, Glimcher LH. Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest. 2007;117:1399-1411.
29. Tilburgs T, Strominger JL. CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity. Am J Reprod Immunol. 2013;69(4):395-407.
30. Zeng W, Liu Z, Liu X, et al. Distinct transcriptional and alternative splicing signatures of decidual CD4+ T cells in early human pregnancy. Front Immunol. 2017;8:682.
31. Nancy P, Tagliani E, Tay CS, Asp P, Levy DE, Erlebacher A. Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. Science. 2012;336(6086):1317-1321.
32. Tagliani E, Erlebacher A. Dendritic cell function at the maternal-fetal interface. Expert Rev Clin Immunol. 2011;7(5):593-602.
33. Tilburgs T, Scherjon SA, Claas FHJ. Major histocompatibility complex (MHC)-mediated immune regulation of decidual leukocytes at the fetal-maternal interface. J Reprod Immunol. 2010;85:58-62.
34. Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science. 1995;270(5236):630-633.
35. Zhou M, Mellor AL. Expanded cohorts of maternal CD8+ T cells specific for paternal MHC Class I accumulate during pregnancy. J Reprod Immunol. 1998;40:47-62.
36. Jiang S-P, Vacchio M. Cutting edge: multiple mechanisms of peripheral T cell tolerance to the fetal “allograft”. J Immunol. 1998;160:3086-3090.
37. Rowe J, Ertelt J, Xin L, Way SS. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature. 2012;490:102-106.
38. Barton BM, Xu R, Wherry EJ, Porrett PM. Pregnancy promotes tolerance to future offspring by programming selective dysfunction in long-lived maternal T cells. J Leukoc Biol. 2017;101(4):975-987.
39. + cytotoxic T cell responses develop during normal human pregnancy and exhibit broad functional capacity. J Immunol. 2012;189:1072-1080.
40. van Kampen CA, Versteeg-van der Voort Maarschalk MFJ, Langerak-Langerak J, van Beelen E, Roelen DL, Claas FHJ. Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum Immunol. 2001;62:201-207.
41. Kalekar LA, Schmiel SE, Nandiwada SL, et al. CD4+ T cell anergy prevents autoimmunity and generates regulatory T cell precursors. Nat Immunol. 2016;17(3):304-314.
42. Lima J, Martins C, Leandro MJ, et al. Characterization of B cells in healthy women from late pregnancy to post-partum: a prospective observational study. BMC Pregnancy Childbirth. 2016; 16(1):139.
43. Muzzio DO, Soldati R, Ehrhardt J, et al. B cell development undergoes profound modifications and adaptations during pregnancy in mice. Biol Reprod. 2014;91(5):115.
44. Fettke F, Schumacher A, Canellada A, et al. B cells: the old new players in reproductive immunology. Front Immunol. 2016;7:495.
45. Amino N, Tanizawa O, Kiyoshi M, et al. Change of serum immunoglobulins IgG, IgA, IgM, and IgE during pregnancy. Obstet Gyncol. 1978;52(4):415-420.
46. Bondt A, Rombouts Y, Selman MHJ, et al. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Mol Cell Proteomics. 2014;13(11):3029-3039.
47. Steele DJ, Laufer TM, Smiley ST, et al. Two levels of help for B cell alloantibody production. J Exp Med. 1996;183(2):699-703.
48. Zeng W, Liu Z, Zhang S, et al. Characterization of T follicular helper cells in allogeneic normal pregnancy and PDL1 blockage-induced abortion. Sci Rep. 2016;6:36560.